Filters

A Abdissa, M F Olsen, D Yilma, M Tesfaye, T Girma, M Christiansen, C M Hagen, L Wiesner, S Castel, A Aseffa, H McIlleron, C Pedersen, H Friis, A B Andersen

HIV medicine 2016;16(7):403-11

Free Full Text

Abstract

Molecular modelling of CYP2B6 based on homology with the CYP2C5 crystal structure: analysis of enzyme-substrate interactions.

David F V Lewis, Brian G Lake, Maurice Dickins, Peter S Goldfarb

Drug metabolism and drug interactions 2003;19(2):115-35

Full Text

Abstract

Assessment of Clinical Drug-Drug Interactions of Elagolix, a Gonadotropin-Releasing Hormone Receptor Antagonist.

Akshanth R Polepally, Juki W Ng, Mohamad Shebley, Nael M Mostafa, Kent Kamradt, David C Carter, Apurvasena Parikh, Matthew B Dufek, Ahmed Hamed Salem

Journal of clinical pharmacology 2021;60(12):1606-1616

Free Full Text

Abstract

ATF5 is a highly abundant liver-enriched transcription factor that cooperates with constitutive androstane receptor in the transactivation of CYP2B6: implications in hepatic stress responses.

Maya Pascual, M José Gómez-Lechón, José V Castell, Ramiro Jover

Drug metabolism and disposition: the biological fate of chemicals 2008;36(6):1063-72

Full Text

Abstract

Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B666 Allele Carriers.

Jason D Robarge, Brian R Overholser, Zeruesenay Desta, James E Tisdale, Heather A Jaynes, Yvonne Kreutz, Jessica Bo Li Lu, Ahmed M Abdelhady, Tyler Shugg, Nancy Thong

Journal of cardiovascular electrophysiology 2017;27(10):1206-1213

Free Full Text

Abstract

Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.

Marija Bosilkovska, Caroline Samer, Julien Déglon, Aurélien Thomas, Bernhard Walder, Jules Desmeules, Youssef Daali

Basic & clinical pharmacology & toxicology 2017;119(3):284-90

Free Full Text

Abstract

Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin.

T Kerbusch, R L Jansen, R A Mathôt, A D Huitema, M Jansen, R E van Rijswijk, J H Beijnen

Clinical pharmacology and therapeutics 2001;70(2):132-41

Full Text

Abstract

Results: 1 – 15 / 16

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Cytochrome P-450 CYP2B6""[mesh_terms]

CYP2B6 Genotype-Dependent Inhibition of CYP1A2 and Induction of CYP2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers.

Multidisciplinary Insights into the Structure-Function Relationship of the CYP2B6 Active Site.

The pharmacogenetics of drug metabolizing enzymes in the Lebanese population.

A brief review of the genetics and pharmacogenetics of opioid use disorders.

Drug-drug interactions between antiretrovirals and hormonal contraception: An updated systematic review.

Genetic Variants of Pregnane X Receptor (PXR) and CYP2B6 Affect the Induction of Bupropion Hydroxylation by Sodium Ferulate.

Analysis of clinically relevant substrates of CYP2B6 enzyme by computational methods.

Cross-linking of human cytochrome P450 2B6 to NADPH-cytochrome P450 reductase: Identification of a potential site of interaction.

Lipid-based nutrient supplements do not affect efavirenz but lower plasma nevirapine concentrations in Ethiopian adult HIV patients.

Molecular modelling of CYP2B6 based on homology with the CYP2C5 crystal structure: analysis of enzyme-substrate interactions.

Assessment of Clinical Drug-Drug Interactions of Elagolix, a Gonadotropin-Releasing Hormone Receptor Antagonist.

ATF5 is a highly abundant liver-enriched transcription factor that cooperates with constitutive androstane receptor in the transactivation of CYP2B6: implications in hepatic stress responses.

Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers.

Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.

Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin.

Results for
""Cytochrome P-450 CYP2B6""[mesh_terms]

Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B666 Allele Carriers.